ArticleToxicology communications2018
Novichok agents: a historical, current, and toxicological perspective.
Article in Toxicology communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 177 citations in OpenAlex.
- Current review on inducible nitric oxide synthase and Src tyrosine kinase inhibitors as disease-modifiers in preclinical models of epilepsy.Histology and histopathology · 2026Review
- Rapid derivatisation of novichok precursor amidines for improved detection by GC-MS.Analytical and bioanalytical chemistry · 2026Article
- Hydrolysis mechanisms for A-series (Novichok) nerve agents at different pH V and computational simulant screening.RSC advances · 2026Article
- Challenges and advances in the development of antidotes against A-series nerve agents.Archives of toxicology · 2026Review
- Integrated multi-omic profiling uncovers endocannabinoid system as a driver of nerve agent-induced cognitive dysfunction in guinea pigs.Archives of toxicology · 2025Article
- Thiophosphoryl-PMMH Dendrimers for Potential Detection and Remediation of CBRN Contamination: Selected Studies and General Guidelines and Procedures.Materials (Basel, Switzerland) · 2025Article
- Diet-incorporated saracatinib, a Src tyrosine kinase inhibitor, counteracts diisopropylfluorophosphate (DFP)-induced chronic neurotoxicity in the rat model.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025Article
- Non-oxime reactivators of organophosphate-inhibited cholinesterases.Archives of toxicology · 2025Review
- Review
- Quantum Chemical Mass Spectral Predictions of Novichok Agents after Experimental Validation and Analysis.ACS measurement science au · 2025Article
- Legacy and impact of the 1925 Geneva Protocol: one hundred years of treaties and debates on chemical and biological weapons.Frontiers in microbiology · 2025Review
- Chemical Warfare Through the Ages: A Systematic Review From Antiquity to the Present.Journal of toxicology · 2025Review
- Synthesis and Evaluation of Halogenated Pralidoximes in Reactivation of Organophosphate-Inhibited Cholinesterases.ACS medicinal chemistry letters · 2024Article
- Evaluation of the Potential of High-Performance Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometry for the Determination of Chemical Warfare Agents and Their Toxic Degradation Products.Molecules (Basel, Switzerland) · 2024Review
- Screening of efficient salicylaldoxime reactivators for DFP and paraoxon-inhibited acetylcholinesterase.RSC medicinal chemistry · 2024Article
- A-series agent A-234: initial in vitro and in vivo characterization.Archives of toxicology · 2024Article
- Novichok Nerve Agents as Inhibitors of Acetylcholinesterase-In Silico Study of Their Non-Covalent Binding Affinity.Molecules (Basel, Switzerland) · 2024Article
- Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication.Protein and peptide letters · 2024Review
- A-agents, misleadingly known as "Novichoks": a narrative review.Archives of toxicology · 2023Review
- Antidotes in Clinical Toxicology-Critical Review.Toxics · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
The
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.